Floatz logo

Trotabresib

Metastatic Malignant Neoplasm in the Leptomeninges

Northwestern UniversitySmall moleculePhase 1Active
D
23/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
8/ 100
Competitive Position
95/ 100

Competitive context

42 Active assets in the Metastatic Malignant Neoplasm in the Leptomeninges cohort.

Asset / SponsorPhaseRating
Cytosin-Arabinosid
Fudan University
Phase 4BBB
METHOTREXATE
The First Affiliated Hospital with Nanjing Medical University
Phase 4BB
TRASTUZUMAB
The First Affiliated Hospital with Nanjing Medical University
Phase 2BB
DEXAMETHASONE
Shanghai Cancer Hospital, China
Phase 2B
Lorlatinib
Guangdong Association of Clinical Trials
Phase 4B

View all 50 →

Same molecule, other indications

Trotabresib is also rated in:

astrocytic tumorDormant
D
Indicative ·
23 / 100
View asset →
breast carcinomaDormant
D
Indicative ·
23 / 100
View asset →
metastatic malignant neoplasm in the brainDormant
D
Indicative ·
23 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →